
Pharmacognosy Practical D Pharm
1. Morphological Identification of the following drugs:
Ispaghula, Senna, Coriander, Fennel, Cardamom, Ginger, Nutmeg, Black Pepper, Cinnamon, Clove, Ephedra, Rauwolfia, Gokhru, Punarnava, Cinchona, Agar.
2. Gross anatomical studies (Transverse Section) of the following drugs:
Ajwain, Datura, Cinnamon, Cinchona, Coriander, Ashwagandha, Liquorice, Clove, Curcuma, Nux vomica, Vasaka
3. Physical and chemical tests for evaluation of any FIVE of the following drugs:
- Asafoetida,
- Benzoin,
- Pale catechu,
- Black catechu,
- Castor oil,
- Acacia,
- Tragacanth,
- Agar,
- Guar gum,
- Gelatine.
Assignments
The students shall be asked to submit the written assignments on the following topics (One assignment per student per sessional period. i.e., a minimum of THREE assignments per student)
1. Market preparations of various dosage forms of Ayurvedic, Unani, Siddha, Homeopathic (Classical and Proprietary), indications, and their labelling requirements
2. Market preparations of various herbal formulations and herbal cosmetics, indications, and their labelling requirements
3. Herb-Drug interactions documented in the literature and their clinical significance
Field Visit
The students shall be taken in groups to a medicinal garden to witness and understand the nature of various medicinal plants discussed in theory and practical courses. Additionally, they shall be taken in groups to the pharmacies of traditional systems of medicines to understand the availability of various dosage forms and their labelling requirements. Individual reports from each student on their learning experience from the field visit shall be submitted.
F Y D Pharm & S Y D Pharm Notes, Books, Syllabus, PDF, Videos
Suggested readings
Recommended readings:
A clinical trial of mRNA HIV vaccine development programme: First-in-Africa by IAVI, Moderna
A clinical trial of mRNA HIV vaccine development programme: First-in-Africa by IAVI, Moderna The nonprofit scientific exploration association IAVI and Moderna,Inc., a biotechnology company introducing runner RNA (mRNA) cures and vaccines, announced that the first party networks are soon to start for a phase I clinical trial of an mRNA HIV vaccine antigen (mRNA-1644) at…
Dishman Carbogen Amcis posted a loss
Dishman Carbogen Amcis posted a loss Dishman Carbogen Amcis, a 2100 Rs. crore plus pharma major has posted a net loss of Rs 45 crore during the fourth quarter ended March 2022 as against net loss ofRs. 135 crore in the corresponding period of last time substantially due to compliances entered from EDQM in respect…
Cipla: Financial performance fourth quarter 2022
Cipla Financial performance fourth quarter 2022 Cipla, aRs. crore plus pharma major has posted dismal fiscal performance during the fourth quarter ended March 2022. Its consolidated net profit declined by 10 per cent toRs. 371 crore from Rs. 412 crore in the matching quarter of last time substantially due to one-time Covid force and other…


